These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

95 related articles for article (PubMed ID: 11046014)

  • 1. Direct NK cell-mediated lysis of syngenic dorsal root ganglia neurons in vitro.
    Backström E; Chambers BJ; Kristensson K; Ljunggren HG
    J Immunol; 2000 Nov; 165(9):4895-900. PubMed ID: 11046014
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Natural killer cell-mediated lysis of dorsal root ganglia neurons via RAE1/NKG2D interactions.
    Backström E; Chambers BJ; Ho EL; Naidenko OV; Mariotti R; Fremont DH; Yokoyama WM; Kristensson K; Ljunggren HG
    Eur J Immunol; 2003 Jan; 33(1):92-100. PubMed ID: 12594837
    [TBL] [Abstract][Full Text] [Related]  

  • 3. IL-18 augments perforin-dependent cytotoxicity of liver NK-T cells.
    Dao T; Mehal WZ; Crispe IN
    J Immunol; 1998 Sep; 161(5):2217-22. PubMed ID: 9725214
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Functional defects of NK cells treated with chloroquine mimic the lytic defects observed in perforin-deficient mice.
    Austin Taylor M; Bennett M; Kumar V; Schatzle JD
    J Immunol; 2000 Nov; 165(9):5048-53. PubMed ID: 11046034
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cutting edge: tumor rejection mediated by NKG2D receptor-ligand interaction is dependent upon perforin.
    Hayakawa Y; Kelly JM; Westwood JA; Darcy PK; Diefenbach A; Raulet D; Smyth MJ
    J Immunol; 2002 Nov; 169(10):5377-81. PubMed ID: 12421908
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Perforin- and Fas-dependent mechanisms of natural killer cell-mediated rejection of incompatible bone marrow cell grafts.
    Taylor MA; Ward B; Schatzle JD; Bennett M
    Eur J Immunol; 2002 Mar; 32(3):793-9. PubMed ID: 11870623
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Perforin is a major contributor to NK cell control of tumor metastasis.
    Smyth MJ; Thia KY; Cretney E; Kelly JM; Snook MB; Forbes CA; Scalzo AA
    J Immunol; 1999 Jun; 162(11):6658-62. PubMed ID: 10352283
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A central role for death receptor-mediated apoptosis in the rejection of tumors by NK cells.
    Screpanti V; Wallin RP; Ljunggren HG; Grandien A
    J Immunol; 2001 Aug; 167(4):2068-73. PubMed ID: 11489989
    [TBL] [Abstract][Full Text] [Related]  

  • 9. IL-18 up-regulates perforin-mediated NK activity without increasing perforin messenger RNA expression by binding to constitutively expressed IL-18 receptor.
    Hyodo Y; Matsui K; Hayashi N; Tsutsui H; Kashiwamura S; Yamauchi H; Hiroishi K; Takeda K; Tagawa Y; Iwakura Y; Kayagaki N; Kurimoto M; Okamura H; Hada T; Yagita H; Akira S; Nakanishi K; Higashino K
    J Immunol; 1999 Feb; 162(3):1662-8. PubMed ID: 9973427
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Enhancement of human cord blood CD34+ cell-derived NK cell cytotoxicity by dendritic cells.
    Yu Y; Hagihara M; Ando K; Gansuvd B; Matsuzawa H; Tsuchiya T; Ueda Y; Inoue H; Hotta T; Kato S
    J Immunol; 2001 Feb; 166(3):1590-600. PubMed ID: 11160200
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Tumor immunity in perforin-deficient mice: a role for CD95 (Fas/APO-1).
    Rosen D; Li JH; Keidar S; Markon I; Orda R; Berke G
    J Immunol; 2000 Mar; 164(6):3229-35. PubMed ID: 10706715
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Distinct requirements for IFNs and STAT1 in NK cell function.
    Lee CK; Rao DT; Gertner R; Gimeno R; Frey AB; Levy DE
    J Immunol; 2000 Oct; 165(7):3571-7. PubMed ID: 11034357
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Adenovirus-interleukin-12-mediated tumor regression in a murine hepatocellular carcinoma model is not dependent on CD1-restricted natural killer T cells.
    Andrews KJ; Ribas A; Butterfield LH; Vollmer CM; Eilber FC; Dissette VB; Nelson SD; Shintaku P; Mekhoubad S; Nakayama T; Taniguchi M; Glaspy JA; McBride WH; Economou JS
    Cancer Res; 2000 Nov; 60(22):6457-64. PubMed ID: 11103813
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Fas ligand (CD95L) protects neurons against perforin-mediated T lymphocyte cytotoxicity.
    Medana I; Li Z; Flügel A; Tschopp J; Wekerle H; Neumann H
    J Immunol; 2001 Jul; 167(2):674-81. PubMed ID: 11441070
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mouse CD94 participates in Qa-1-mediated self recognition by NK cells and delivers inhibitory signals independent of Ly-49.
    Toyama-Sorimachi N; Taguchi Y; Yagita H; Kitamura F; Kawasaki A; Koyasu S; Karasuyama H
    J Immunol; 2001 Mar; 166(6):3771-9. PubMed ID: 11238619
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Disparate effect of beige mutation on cytotoxic function between natural killer and natural killer T cells.
    Bannai M; Oya H; Kawamura T; Naito T; Shimizu T; Kawamura H; Miyaji C; Watanabe H; Hatakeyama K; Abo T
    Immunology; 2000 Jun; 100(2):165-9. PubMed ID: 10886391
    [TBL] [Abstract][Full Text] [Related]  

  • 17. In vitro- and ex vivo-derived cytolytic leukocytes from granzyme A x B double knockout mice are defective in granule-mediated apoptosis but not lysis of target cells.
    Simon MM; Hausmann M; Tran T; Ebnet K; Tschopp J; ThaHla R; Müllbacher A
    J Exp Med; 1997 Nov; 186(10):1781-6. PubMed ID: 9362539
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Differential antitumor effects of administration of recombinant IL-18 or recombinant IL-12 are mediated primarily by Fas-Fas ligand- and perforin-induced tumor apoptosis, respectively.
    Hashimoto W; Osaki T; Okamura H; Robbins PD; Kurimoto M; Nagata S; Lotze MT; Tahara H
    J Immunol; 1999 Jul; 163(2):583-9. PubMed ID: 10395644
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Molecular mechanisms of immune-mediated lysis of murine renal cancer: differential contributions of perforin-dependent versus Fas-mediated pathways in lysis by NK and T cells.
    Sayers TJ; Brooks AD; Lee JK; Fenton RG; Komschlies KL; Wigginton JM; Winkler-Pickett R; Wiltrout RH
    J Immunol; 1998 Oct; 161(8):3957-65. PubMed ID: 9780164
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Perforin dependence of natural killer cell-mediated tumor control in vivo.
    van den Broek MF; Kägi D; Zinkernagel RM; Hengartner H
    Eur J Immunol; 1995 Dec; 25(12):3514-6. PubMed ID: 8566046
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.